Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound

This LCD (L39879) states that all injections or applications of amniotic membrane, amniotic fluid, or other placental-derived products for any musculoskeletal indication are not reasonable, necessary, and are non-covered. The policy does not address burns, wounds, or ophthalmic uses, excludes dental uses as non-benefit, and directs consideration of FDA regulatory status and NCD 110.23 for stem-cell-related therapies.

"All amniotic membrane, amniotic fluid, and other placental-derived product injections or applications for the diagnosis or management of any musculoskeletal condition (including joint pain, tendon/..."

Sign up to see full coverage criteria, indications, and limitations.